The strain at the heart of the work, designated BWBTDIPO1 and deposited in GenBank under accession number PQ517523, was isolated from a waste-dumping zone in Kolkata. That provenance matters. Bacteria that thrive in garbage dumps are often exposed to complex, recalcitrant organic matter, and the team suspected such an environment might select for organisms capable of dismantling lignocellulose — the tough composite of lignin, cellulose, and hemicellulose that makes plant waste so resistant to decay and so expensive to process industrially. Their hunch proved correct. When the researchers offered the bacterium ground, sterilized sugarcane bagasse as its sole carbon source in submerged fermentation, the microbe grew vigorously and secreted riboflavin into the surrounding medium.

The numbers are compelling. Over a 78-hour fermentation at 30 degrees Celsius and 120 rpm, the bacterium achieved a specific growth rate of 0.325 per hour, corresponding to a generation time of roughly 2.13 hours, and produced 397 ± 15.8 milligrams of riboflavin per liter of culture — equivalent to 19.85 ± 2.0 milligrams of the vitamin for every gram of bagasse consumed. The team screened four mineral salt medium formulations to find the optimal recipe, and yeast extract peptone mineral salt medium, or YPMSM, emerged as the clear winner. The authors attribute this to the synergistic nutritional boost provided by yeast extract and peptone, which supply vitamins, nucleotides, peptides, and growth factors that support flavin biosynthesis and the enzymatic machinery needed to break down the biomass.

The growth curve told a classic batch-fermentation story with a twist. The bacterium lingered in a lag phase until about the sixteenth hour — a period the researchers interpret as physiological adaptation to the complex, lignin-rich substrate — then exploded into exponential growth between hours 18 and 40, before settling into a stationary phase. Riboflavin production tracked this trajectory closely, accelerating sharply after hour 18 and continuing into the late exponential and early stationary phases before peaking at hour 78. This pattern suggests the vitamin is produced through a combination of growth-associated and non-growth-associated mechanisms, a detail the authors say will be critical for timing cell harvesting and product recovery in any future industrial scale-up.

Confirming that the yellow-green metabolite really was riboflavin required a two-pronged analytical approach. Ultraviolet-visible spectrophotometry of the acidified ethanol extract revealed absorption peaks at 226 and 266 nanometers, matching the signature of riboflavin’s isoalloxazine chromophore. Thin-layer chromatography on silica gel plates, using a methanol-to-water mobile phase of 70:30, produced a retention factor of 0.83 — identical to that of a commercially purchased riboflavin standard run alongside the sample. Earlier work by the same group had already achieved a higher yield of 459.31 milligrams per liter using Luria Bertani broth, a glucose-rich synthetic medium, but the current process substitutes a zero-cost agricultural waste for that expensive feedstock, dramatically improving the economics even at a slightly lower titer.

Perhaps the most technically revealing portion of the study concerns what happened to the bagasse itself. The researchers subjected treated and untreated biomass to a battery of compositional assays. Alkali lignin solubilization increased measurably after bacterial treatment, with optical density at 465 nanometers rising from 0.359 in untreated samples to 0.443 in treated ones. Acid hydrolysis revealed a dramatic 65.33 ± 3.4 percent reduction in acid-insoluble lignin — the most condensed and structurally resistant lignin fraction — falling from 0.75 grams of residual dry biomass to just 0.26 grams. Meanwhile, the dinitrosalicylic acid assay showed reducing sugar concentrations more than tripling, from 0.205 to 0.617 milligrams per milliliter, direct evidence that the bacterium was hydrolyzing cellulose and hemicellulose polymers into fermentable monosaccharides such as glucose, xylose, and arabinose.

Physicochemical characterization painted the same picture at the molecular and microscopic scales. Fourier-transform infrared spectroscopy revealed shifts and disappearances in peaks associated with lignin-carbohydrate complexes: the aromatic skeletal vibration near 1,634 wavenumbers shifted to 1,607, the crystalline cellulose CH2 wagging peak at 1,317 vanished entirely, and a new peak appeared at 1,244 wavenumbers, consistent with disruption of aryl-alkyl ether linkages binding hemicellulose to lignin. X-ray diffraction showed a sharper, more intense cellulose diffraction peak in treated samples, indicating that removal of amorphous lignin and hemicellulose had exposed the crystalline cellulose microfibrils beneath. Field-emission scanning electron microscopy provided the most visceral confirmation: where untreated bagasse displayed a dense, smooth, intact fibrillar architecture, the bacterially treated material was riddled with erosion, fragmentation, pore formation, and pronounced cracking.

To explain these observations mechanistically, the team turned to computational biology. Using KEGG global metabolic pathway mapping, they constructed a hypothetical framework for how the bacterium might be routing biomass-derived carbon through its metabolism. The analysis suggests three interconnected routes: lignin-derived aromatic compounds funneled into the tricarboxylic acid cycle, cellulose hydrolyzed to cellobiose and glucose before entering glycolysis, and hemicellulose-derived pentose sugars like xylose and arabinose assimilated through the pentose phosphate pathway. The authors are careful to emphasize that these pathways are predictive annotations, not experimentally validated mechanisms, and will require genomic, transcriptomic, proteomic, metabolomic, and enzyme-activity studies to confirm. Still, the architecture is consistent with lignocellulose degradation strategies documented in other bacteria and provides a plausible explanation for how biomass carbon ends up as riboflavin.

The significance of the work extends well beyond one bacterium and one vitamin. Global riboflavin production still relies heavily on chemical synthesis routes that demand multistep reactions, expensive catalysts, and energy-intensive operations, while most biological production depends on genetically modified organisms such as engineered Escherichia coli and Corynebacterium glutamicum. A wild-type strain that achieves competitive yields from free agricultural waste sidesteps both problems. India, one of the world’s leading sugarcane producers, generates enormous quantities of bagasse annually, and disposing of it poses persistent environmental challenges. Coupling that waste stream to nutraceutical manufacturing embodies the waste-to-wealth vision of the circular bioeconomy, and the authors note the approach aligns with broader sustainability goals.

Considerable work remains before a Kolkata dump-dwelling microbe can feed a factory. The researchers themselves flag the next steps: whole-genome sequencing to identify the genes governing both lignocellulose degradation and flavin biosynthesis, process optimization to push yields higher, techno-economic analysis, and life cycle assessment to verify the environmental credentials at scale. They also point out that the strain produced its riboflavin without any external supplementation of cofactors or amino acids, a simplicity that bodes well for cost-sensitive industrial adoption. If those efforts succeed, the humble bagasse pile behind every sugarcane juice cart could become a feedstock for one of the world’s most widely consumed vitamins — proof that sometimes the most valuable chemistry is already happening, quietly, in the dirt of a garbage dump.

Subject of Research: Bacterial bioconversion of sugarcane bagasse waste into riboflavin (vitamin B2)

Article Title: Sustainable bioconversion of sugarcane bagasse into valorizable riboflavin by Microbacterium proteolyticum BWBTDIPO1, characterization and in-silico mechanistic pathway prediction

Article References: Paul, I., Kali, S., Saha, S., Guha, P., Dasgupta, S., & Halder, G. (2026). Sustainable bioconversion of sugarcane bagasse into valorizable riboflavin by Microbacterium proteolyticum BWBTDIPO1, characterization and in-silico mechanistic pathway prediction. Frontiers in Chemical Engineering, 8, Article 1895508. https://doi.org/10.3389/fceng.2026.1895508

Image Credits: AI Generated

DOI: 10.3389/fceng.2026.1895508

Keywords: riboflavin, vitamin B2, sugarcane bagasse, Microbacterium proteolyticum, lignocellulosic biomass, submerged fermentation, biorefinery, waste-to-wealth, circular bioeconomy, KEGG pathway analysis, FTIR, biodegradation

The research, led by Yao Peng and Yong Tan of Nanjing University of Chinese Medicine together with colleagues, set out to map what actually happens inside ovarian tissue after repeated exposure to cyclophosphamide. Working with a rat model of multiple drug exposures, the team combined two powerful approaches: they measured the activity of circadian rhythm genes in the ovary, and they ran proteomic analysis to survey the full complement of proteins whose abundance shifted after treatment. The results converged on a surprising culprit. The ovaries of drug-exposed animals showed abnormal expression of circadian rhythm genes, and proteomics revealed a dramatic drop in one protein in particular: riboflavin kinase, abbreviated RFK, the enzyme that initiates the cellular processing of vitamin B2.

That finding might sound obscure, but riboflavin kinase sits at the head of a metabolic pathway with far-reaching consequences. The enzyme converts riboflavin, the vitamin better known as B2, into flavin mononucleotide, which is then elaborated into flavin adenine dinucleotide, or FAD, one of the most indispensable cofactors in biology. FAD participates in hundreds of redox reactions, shuttling electrons through the metabolic machinery that keeps cells alive. The new study adds a second, less appreciated role to that list: FAD is also a structural partner for the circadian clock, because it competes with the clock proteins cryptochrome 1 and 2 for binding to the ubiquitin E3 ligase, the cellular machine that tags proteins for destruction.

Here is where the chemistry becomes elegant. Cryptochromes are the workhorse repressors of the mammalian circadian oscillator, the proteins that help cells keep a roughly 24-hour rhythm of gene activity. Like all proteins, they are constantly being built and broken down, and the ubiquitin E3 ligase is responsible for their degradation. FAD competes with the cryptochrome proteins for access to that ligase, which means that when FAD levels are adequate, the degradation machinery is partially occupied and the cryptochromes survive longer, stabilizing the clock. When FAD runs short, the ligase turns its full attention to cryptochrome 1 and 2, and the clock proteins are chewed up faster than the cell can replace them.

The rat experiments showed precisely this sequence unfolding after cyclophosphamide exposure. Riboflavin kinase expression fell, riboflavin metabolism faltered, FAD synthesis was inhibited, and the cryptochrome proteins were degraded at an accelerated rate. The circadian rhythm regulation of the ovary, a tissue whose follicular development, hormone secretion and ovulation are all coordinated by daily molecular rhythms, fell into disarray. In other words, the chemotherapy drug was not only attacking the DNA of dividing granulosa cells; it was quietly dismantling the metabolic and temporal infrastructure those cells depend on to function.

To test whether the connection was causal rather than coincidental, the researchers turned to molecular experiments in which they knocked down riboflavin kinase directly. The results reinforced the model. Suppressing the enzyme lowered levels of FAD synthase, the downstream enzyme that completes FAD production, and it worsened the degradation of cryptochrome 1 and 2. Circadian rhythm regulation was disrupted, and the consequences rippled into the function of ovarian granulosa cells, the somatic cells that nurse developing follicles and produce the hormones essential for fertility. With their clock destabilized and their metabolism compromised, the granulosa cells declined, and ovarian aging accelerated.

The most clinically tantalizing result came from the rescue experiment. When the researchers supplemented the system with FAD, the cascade of damage was mitigated. Restoring the flavin cofactor eased the pressure on the cryptochrome proteins, helped re-establish circadian regulation and protected granulosa cell function. In the framework of the study, FAD supplementation acted as a counterweight to the riboflavin metabolism defect that cyclophosphamide had created, suggesting a potential strategy for shielding the ovary during chemo. The authors conclude that cyclophosphamide can impair ovarian function by causing dysregulation of riboflavin metabolism, which in turn drives abnormal circadian rhythms.

The implications extend beyond oncology. Premature ovarian insufficiency affects roughly one percent of women and carries consequences that reach far beyond fertility, including bone loss, cardiovascular risk and psychological distress. If a substantial share of chemotherapy-induced ovarian damage is mediated through a metabolic cofactor rather than through DNA strand breaks alone, then the protective options broaden considerably. Dietary and pharmacological interventions aimed at preserving riboflavin metabolism, or at stabilizing cryptochrome proteins directly, could in principle complement the existing approaches to fertility preservation, which currently rely on egg or embryo freezing and on temporary ovarian suppression with hormonal analogs during treatment.

The study also adds the ovary to a growing list of tissues whose health appears to depend on the integrity of their peripheral circadian clocks. Circadian biologists have shown that nearly every organ runs its own internal timing system, synchronized by the brain’s master clock but capable of autonomous oscillation, and that disrupting these local clocks impairs tissue function. The ovary is an especially rhythm-sensitive organ: follicle maturation, steroidogenesis and ovulation follow daily patterns, and granulosa cells express clock genes whose cycling is thought to coordinate these processes. A chemotherapeutic agent that destabilizes cryptochrome proteins in granulosa cells is therefore attacking the ovary at a level that standard genotoxicity models never captured.

As with any animal study, the road from rat ovaries to human clinics is long, and the findings, published open access with support from the National Natural Science Foundation of China, will need validation in human ovarian tissue and eventually in patients. The dosing, timing and safety of FAD supplementation alongside chemotherapy remain to be established, and it is far too early for patients undergoing cyclophosphamide treatment to draw practical conclusions. But the study reframes a familiar hazard in a new light. A drug long understood as a DNA-damaging agent now appears to sabotage the ovary through a second route, by starving it of a vitamin-derived cofactor that keeps its cellular clocks running, and that second route, unlike DNA damage itself, may be one medicine can actually repair.

Subject of Research: Mechanisms of cyclophosphamide-induced ovarian damage via riboflavin metabolism and circadian rhythm disruption

Article Title: Cyclophosphamide as a reproductive hazard: disrupted riboflavin metabolism and circadian rhythms drive ovarian decline

Article References: Peng, Y., Ma, Z., Hu, D., Wu, S., Shi, J., Chen, J., & Tan, Y. (2026). Cyclophosphamide as a reproductive hazard: disrupted riboflavin metabolism and circadian rhythms drive ovarian decline. Journal of Ovarian Research. https://doi.org/10.1186/s13048-026-02293-6

Image Credits: AI Generated

DOI: 10.1186/s13048-026-02293-6

Keywords: cyclophosphamide, ovarian aging, premature ovarian insufficiency, riboflavin kinase, FAD, cryptochrome, circadian rhythm, granulosa cells, chemotherapy, fertility, vitamin B2, ovary

Endosymbiosis, the phenomenon in which one organism lives inside the cells of another, underlies some of the most important transitions in the history of life. Mitochondria and chloroplasts, the energy-converting organelles of eukaryotic cells, are the descendants of free-living bacteria that took up residence inside ancestral host cells more than a billion years ago. Wolbachia, an alpha-proteobacterium related to the ancestors of mitochondria, is arguably the most successful animal-associated microbe on Earth, colonizing an estimated 50 to 60 percent of all insect and arthropod species as well as filarial nematodes. Depending on the host and the bacterial strain, the relationship ranges from reproductive parasitism to strict mutualism, in which the host can no longer survive without its passenger.

In filarial worms such as Wuchereria bancrofti, the cause of elephantiasis, and Onchocerca volvulus, the agent of river blindness, the mutualism has become so intimate that antibiotic killing of Wolbachia also kills the worm. In insects, the bacterium can supply essential metabolites including heme, purines, pyrimidines, flavin adenine dinucleotide and riboflavin, and it can suppress infections by pathogenic viruses, bacteria and protists. Yet modeling the early stages of such coevolution in insects or nematodes is slow and experimentally awkward, because adaptive changes in these animals take generations to accumulate. Yeast, with its rapid doubling time and fully sequenced, easily manipulated genome, offers an appealing alternative, particularly since recent surveys have revealed that wild yeasts, long considered axenic, actually harbor hidden communities of intracellular bacteria.

To build their model, the Mexican team exploited two deletion mutants of the laboratory strain By4742. The first, ΔRIB1, lacks GTP cyclohydrolase II, the enzyme that catalyzes the very first step of riboflavin biosynthesis. The second, ΔRIB4, lacks lumazine synthase, which manufactures the immediate precursor of the vitamin. When the researchers grew these strains in a synthetic lactate medium lacking riboflavin, both mutants failed to grow, while the wild-type strain reached measurable densities and grew slightly better when the vitamin was added. The auxotrophy was not an artifact of the carbon source: the mutants also failed to grow without riboflavin in dextrose-containing medium, confirming that the defect lay squarely in the vitamin’s synthesis pathway rather than in respiratory metabolism per se.

Biochemical measurements reinforced the picture. Using a Clark-type oxygen electrode, the team found that both mutants consumed oxygen at very low rates, consistent with their dependence on riboflavin-derived cofactors. Riboflavin is the substrate for the synthesis of flavin mononucleotide and flavin adenine dinucleotide, the two redox coenzymes that power oxidative metabolism and a host of other cellular reactions. Fluorescence-based quantification of intracellular flavins showed that the mutants contained roughly half the riboflavin of wild-type cells, and that exogenous supplementation raised their internal levels, with ΔRIB4 responding particularly strongly. The uncoupling agent CCCP increased oxygen consumption in all strains, indicating that the respiratory machinery itself remained responsive and that the bottleneck was cofactor supply.

The pivotal experiment came next. The researchers infected the yeast strains with Wolbachia strain wStr, originally isolated from the planthopper Laodelphax striatellus and maintained in an Aedes albopictus cell line. Infection was accomplished by co-centrifuging bacteria and yeast and was confirmed seven days later by reverse-transcription PCR amplification of the wsp gene, which encodes the bacterium’s major surface protein. A 650-base-pair product appeared in all infected strains but not in uninfected controls. Strikingly, when the infected ΔRIB1 and ΔRIB4 mutants were grown in medium lacking riboflavin, they grew to levels comparable to those achieved with vitamin supplementation, demonstrating that the endosymbiont had functionally complemented the missing biosynthetic steps.

Physiological assays supported the conclusion that the bacterium was genuinely provisioning its host. Oxygen consumption, which had been negligible in the uninfected auxotrophs, rose significantly after infection, with the largest gains seen in maximal, uncoupled respiration. Intracellular riboflavin concentrations increased in both infected mutants, more modestly in wΔRIB1 and more pronouncedly in wΔRIB4. The team also tested whether infection conferred broader physiological benefits by exposing cells to two harsh conditions: one molar sodium chloride, an ionic stress, and ten millimolar hydrogen peroxide, which generates reactive oxygen species. Infected mutants survived these challenges at substantially higher rates than their uninfected counterparts. Under salt stress, survival of ΔRIB1 rose from 34 to 71 percent and that of ΔRIB4 from 11 to 37 percent; under peroxide, ΔRIB1 improved from 41 to 75 percent and ΔRIB4 from 37 to 57 percent. The wild-type strain showed little change, suggesting that the benefit is most visible when the host is metabolically vulnerable.

The mechanism most likely centers on Wolbachia‘s own riboflavin pathway, which retains a conserved set of six genes, ribA, ribD, ribB, ribE, ribC and ribF, across diverse insect-associated strains. Parallel examples abound in nature. The bed bug Cimex lectularius depends on its Wolbachia for B-vitamin synthesis during blood digestion, the brown planthopper Nilaparvata lugens receives both biotin and riboflavin from its symbiont, and in the tomato psyllid, co-resident Liberibacter and Wolbachia jointly enhance host fitness by supplying arginine and riboflavin. Beyond nutrient transfer, the bacterium’s type IV secretion system and its ankyrin repeat-containing proteins may modulate host cell processes, a strategy documented both in mosquitoes and, notably, in S. cerevisiae itself in earlier work by the same group.

That earlier work, published in 2019, showed that Wolbachia pipientis strain wAlbB infecting yeast W303 deregulated mitochondrial oxidative phosphorylation and hastened host death, a clearly parasitic outcome. The new study therefore captures a different face of the same bacterium: in a host with a specific metabolic vulnerability, infection becomes advantageous rather than lethal, at least in the short term. The authors caution that the benefits are likely transient, since prolonged infection has been shown to induce mitochondrial dysregulation and early cell death in yeast, and they note that the iron supplementation used in their media may itself have supported both symbiont growth and mitochondrial function through heme and iron-sulfur cluster assembly. Even so, the system neatly recapitulates the trajectory from parasite to mutualist that Wolbachia follows in nature, and it does so in an organism whose genetics, metabolism and respiratory physiology are among the best characterized in biology.

The researchers argue that the artificial yeast-endosymbiont model could become a standard platform for dissecting the molecular details of metabolic complementation: which compartments participate in riboflavin trafficking, how nutrient exchange is regulated, and how bacterial effectors reshape host physiology. Because the host is a single-celled eukaryote with a short generation time, experiments that would take years in insects can be completed in days. In an era when Wolbachia is being deployed at continental scale to suppress mosquito-borne diseases such as dengue, understanding the spectrum of its interactions with host cells, from exploitation to essential provisioning, has practical as well as evolutionary significance. This study shows that the first steps of that spectrum can now be reproduced, observed and manipulated in a test tube, one vitamin at a time.

Subject of Research: Wolbachia-mediated rescue of riboflavin auxotrophy in Saccharomyces cerevisiae as a model of endosymbiotic mutualism

Article Title: In Saccharomyces cerevisiae ΔRIB1 and ΔRIB4 mutants, riboflavin auxotrophy is reverted by Wolbachia (wStr) infection

Article References: Mendez-Romero, O., Ricardez-García, C., & Uribe-Carvajal, S. (2026). In Saccharomyces cerevisiae ΔRIB1 and ΔRIB4 mutants, riboflavin auxotrophy is reverted by Wolbachia (wStr) infection. International Microbiology. https://doi.org/10.1007/s10123-026-00884-3

Image Credits: AI Generated

DOI: 10.1007/s10123-026-00884-3

Keywords: Wolbachia, Saccharomyces cerevisiae, riboflavin auxotrophy, endosymbiosis, mutualism, vitamin B2, flavin cofactors, mitochondrial respiration, oxidative stress, wStr strain, yeast model, symbiotic complementation